Teppei Okamoto

1.2k total citations
93 papers, 805 citations indexed

About

Teppei Okamoto is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Teppei Okamoto has authored 93 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 33 papers in Surgery and 16 papers in Oncology. Recurrent topics in Teppei Okamoto's work include Bladder and Urothelial Cancer Treatments (24 papers), Prostate Cancer Treatment and Research (21 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Teppei Okamoto is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Prostate Cancer Treatment and Research (21 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Teppei Okamoto collaborates with scholars based in Japan, United Kingdom and United States. Teppei Okamoto's co-authors include Chikara Οhyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Tohru Yoneyama, Shingo Hatakeyama, Naoki Fujita, Atsushi Imai and Itsuto Hamano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Teppei Okamoto

87 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teppei Okamoto Japan	16	256	209	138	130	116	93	805
Itsuto Hamano Japan	15	268 1.0×	274 1.3×	101 0.7×	100 0.8×	113 1.0×	48	625
Suzanne Stewart United States	14	565 2.2×	343 1.6×	210 1.5×	129 1.0×	65 0.6×	30	1.0k
Vikram M. Narayan United States	17	219 0.9×	283 1.4×	130 0.9×	28 0.2×	171 1.5×	101	761
Xuejiao Wei Canada	19	233 0.9×	376 1.8×	327 2.4×	22 0.2×	77 0.7×	68	1.0k
Laura Greco Italy	16	231 0.9×	258 1.2×	68 0.5×	37 0.3×	18 0.2×	56	900
Fabrizio Gallo Italy	15	288 1.1×	292 1.4×	70 0.5×	13 0.1×	212 1.8×	55	801
Yee-Yung Ng Taiwan	12	205 0.8×	243 1.2×	52 0.4×	31 0.2×	25 0.2×	26	1.1k
Timothy D. Lyon United States	15	228 0.9×	274 1.3×	76 0.6×	9 0.1×	127 1.1×	81	646
Steven T. Bird United States	16	97 0.4×	69 0.3×	68 0.5×	10 0.1×	45 0.4×	31	736
Riccardo Lombardo Italy	19	761 3.0×	298 1.4×	96 0.7×	15 0.1×	640 5.5×	125	1.5k

Countries citing papers authored by Teppei Okamoto

Since Specialization

Citations

This map shows the geographic impact of Teppei Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teppei Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teppei Okamoto more than expected).

Fields of papers citing papers by Teppei Okamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teppei Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teppei Okamoto. The network helps show where Teppei Okamoto may publish in the future.

Co-authorship network of co-authors of Teppei Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Teppei Okamoto. A scholar is included among the top collaborators of Teppei Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teppei Okamoto. Teppei Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miura, Yuki, Tohru Yoneyama, Hayato Yamamoto, et al.. (2025). Analytical and Real‐World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population. The Prostate. 85(9). 869–887. 4 indexed citations

Yoneyama, Tohru, Yuki Miura, Akio Yoneyama, et al.. (2025). The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies. The Prostate. 85(11). 1062–1068. 3 indexed citations

Numakura, Kazuyuki, Masanao Shinohara, Mizuki Kobayashi, et al.. (2025). Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma. Scientific Reports. 15(1). 26127–26127. 1 indexed citations

Kato, Taigo, Junya Furukawa, Nobuyuki Hinata, et al.. (2024). Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. International Journal of Clinical Oncology. 30(1). 99–109. 2 indexed citations

Tanaka, Ryuma, Fumiya Yoneyama, Naoki Fujita, et al.. (2024). Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer. Cancer Medicine. 13(24). e70226–e70226. 2 indexed citations

Fujita, Naoki, Masaki Momota, Yuki Tobisawa, et al.. (2023). Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study. The World Journal of Men s Health. 41(4). 900–900. 1 indexed citations

Hatakeyama, Shingo, Tohru Yoneyama, Yuki Tobisawa, et al.. (2023). Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab. Scientific Reports. 13(1). 15098–15098. 3 indexed citations

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2022). Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study. The World Journal of Men s Health. 41(2). 373–373. 1 indexed citations

Hatakeyama, Shingo, Hideo Kawaguchi, Yoshiomi Hatayama, et al.. (2021). Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study. Urologic Oncology Seminars and Original Investigations. 40(2). 64.e1–64.e8. 11 indexed citations

10.

Hatakeyama, Shingo, Teppei Okamoto, Yuta Kojima, et al.. (2021). Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years. Urologic Oncology Seminars and Original Investigations. 39(10). 729.e17–729.e25. 11 indexed citations

11.

Momota, Masaki, Shingo Hatakeyama, Osamu Soma, et al.. (2020). Geriatric 8 screening of frailty in patients with prostate cancer. International Journal of Urology. 27(8). 642–648. 33 indexed citations

12.

Hatakeyama, Shingo, Atsushi Imai, Mika Kumagai, et al.. (2020). A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project. Urologia Internationalis. 105(3-4). 232–239. 9 indexed citations

13.

Hatakeyama, Shingo, Yuta Kojima, Masaki Momota, et al.. (2020). The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study). Urologic Oncology Seminars and Original Investigations. 39(3). 192.e7–192.e14. 9 indexed citations

14.

Okamoto, Teppei, Shingo Hatakeyama, Atsushi Imai, et al.. (2020). The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan. International Urology and Nephrology. 52(8). 1421–1428. 25 indexed citations

15.

Okamoto, Teppei, Shingo Hatakeyama, Shintaro Narita, et al.. (2018). Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan. World Journal of Urology. 37(9). 1827–1835. 47 indexed citations

16.

Okamoto, Teppei, Shingo Hatakeyama, Yoshimi Tanaka, et al.. (2018). Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study. Clinical and Experimental Nephrology. 22(5). 1174–1181. 6 indexed citations

17.

Tanaka, Yoshimi, Shingo Hatakeyama, Toshikazu Tanaka, et al.. (2017). The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis. PLoS ONE. 12(7). e0182136–e0182136. 21 indexed citations

18.

Hamano, Itsuto, Teppei Okamoto, Hayato Yamamoto, et al.. (2014). Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient. Case Reports in Oncology. 7(1). 233–238. 4 indexed citations

19.

Okamoto, Teppei, Shingo Hatakeyama, Kazuyuki Mori, et al.. (2012). Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity. Molecular Medicine Reports. 7(2). 359–364. 42 indexed citations

20.

Yoneyama, Tohru, Shingo Hatakeyama, Yuki Tobisawa, et al.. (2012). Blood Group Antigen-Targeting Peptide Suppresses Anti-Blood Group Antibody Binding to Antigen in Renal Glomerular Capillaries After ABO-Incompatible Blood Reperfusion. Transplantation. 95(3). 418–425. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact